Walvax Biotechnology Co.,Ltd.’s Net Profit Rose 23.2% in First Half of 2022

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (300142.SZ) reported a net profit of 502 million yuan in the first half of 2022, up 23.2% year-on-year.

Meanwhile, the company posted 2.3 billion yuan in revenue, up 74% year-on-year.

At the end of the reporting period, it had 15 billion yuan in total assets and 4.2 billion yuan in total liabilities, with a liability-to-asset ratio of 28.3%.